Noetik’s TARIO-2: A ‘world model’ that reads a tumor from a single slide
Many patients who receive cancer immunotherapy do not respond to it, and oncologists still have few dependable ways to know in advance who will. By one estimate, only about 13% of all U.S. cancer…
Read the full articleYou might also wanna read
MilliporeSigma’s CTO on AI retrosynthesis, the Merck KGaA–Siemens deal and the chemistry that runs the autonomous lab
rdworldonline.com·17d ago
Waters targets large, heterogeneous drug modalities with three new mass spectrometry systems
rdworldonline.com·9d ago
Benchtop NMR systems bring nuclear magnetic resonance to the laboratory bench
news-medical.net·9d agoCountable Labs’ CTO Christina Fan on reimagining PCR, one molecule at a time
rdworldonline.com·10d ago
AI-Driven Protein Binder Design: Progress and Pitfalls in Evaluation Practices
boltz.bio·10d agoBioPharma Supply Chain & Logistics Nexus returns to San Diego in November
rdworldonline.com·15d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.